disorders have been compared between the study groups, based on the results of which there has been no statistically significant difference between the case and control group in respect to these variables (P > 0.05).
The results of the comparison of the mean score of "SCARED" and "CATS" between the case and control groups at the beginning of the study, early after termination of treatment and 3 months after treatment are presented in Table 2 . As it's seen, during all of the study time periods, the mean score of "SCARED" in control group has been higher than in the case group. However, there has been no statistically significant difference between two groups (P > 0.05). Also, no significant difference in the mean score of "CATS" during the study time periods has been observed (P > 0.05). The results of repeated measurements of ANOVA test in investigating the process of decrease in values of "SCARED" [ Figure 2 ] and "CATS" [ Figure 3 ] during the evaluation time periods revealed that there was no statistically significant difference in decreasing process of these variables in both groups of case and control (P > 0.05). Moreover, during none of study time periods, there was a significant differences in the mean score of "SCARED" and "CATS" between the study groups based on the type of anxiety disorder. There were no side effects in both of the studied groups' patients.
Discussion
The present study was conducted with the aim of investigating the effect of DCS coupled with CBT on adolescents with anxiety disorders. Our results revealed that the mean score of "SCARED" has been higher in the control group than in the case group. However, the difference is not statistically significant. The mean score of "CATS", also, was not significantly different between groups during any of the study time periods. These results show that adding 50 mgs of DCS to the CBT protocol of the patients has led to no significant difference in the result of the treatment in DCS-receptor patients compared to placebo-receptor ones. Furthermore, the mean score of "SCARED" and "CATS" during the study time periods in the study groups, based on the anxiety disorder types, showed no statistically significant difference. However, considering the frequency distribution of the anxiety disorder type in the study patients, despite the insignificance of this difference, the statistical power in showing the difference between groups may be low due to low frequency of these disorders among the study groups. In addition, in some patients, there are several anxiety disorders, making it difficult to differentiate drug effects based on the type of anxiety disorder.
In a systematic review study in 2010, Ganasen et al. [33] showed that prescribing DCS before CBT sessions would Figure 3 : Comparison of means of CATS scores between study groups during 4 months study period. In both groups after the study means of CATS were decreased compared to before study and differences between groups was not statistically significant (P value = 0.33) Figure 2 : Comparison of means of SCARED Scores between study groups during 4 months study period. In both groups after the study means of scared were decreased compared to before study and differences between groups was not statistically significant (P = 0.49) 
